Literature DB >> 23355261

Global subendocardial late gadolinium enhancement on cardiac magnetic resonance imaging in severe cardiac AL amyloidosis.

Minako Mori1, Tomoya Kitagawa, Yuya Sasaki, Takashi Onaka, Akihito Yonezawa, Kazunori Imada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23355261     DOI： 10.1007/s12185-013-1259-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  5 in total

1.  Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.

Authors:  Ralf Wassmuth; Hassan Abdel-Aty; Steffen Bohl; Jeanette Schulz-Menger
Journal:  Eur Radiol       Date:  2011-03-29       Impact factor: 5.315

2.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

3.  Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.

Authors:  Arsene Mekinian; Christophe Lions; Xavier Leleu; Alain Duhamel; Nicolas Lamblin; Valerie Coiteux; Pascal De Groote; Pierre-Yves Hatron; Thierry Facon; Jean-Paul Beregi; Eric Hachulla; David Launay
Journal:  Am J Med       Date:  2010-09       Impact factor: 4.965

4.  Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

Authors:  Giovanni Palladini; Carlo Campana; Catherine Klersy; Alessandra Balduini; Giovanbattista Vadacca; Vittorio Perfetti; Stefano Perlini; Laura Obici; Edoardo Ascari; Gianvico Melzi d'Eril; Remigio Moratti; Giampaolo Merlini
Journal:  Circulation       Date:  2003-04-28       Impact factor: 29.690

5.  Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis.

Authors:  Stephanie Lehrke; Henning Steen; Arnt V Kristen; Constanze Merten; Dirk Lossnitzer; Thomas J Dengler; Hugo A Katus; Evangelos Giannitsis
Journal:  Amyloid       Date:  2009-12       Impact factor: 7.141
  5 in total
  1 in total

Review 1.  Clinical Use of Cardiac Magnetic Resonance in Systemic Heart Disease.

Authors:  Sophie Mavrogeni; George Markousis-Mavrogenis; Genovefa Kolovou
Journal:  Eur Cardiol       Date:  2014-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.